Serving as a quaternary referral center, we give patients access to innovative procedures and devices only available at select centers.
Author: Megan Davis
Hypertrophic cardiomyopathy has historically been less well-understood than other cardiac conditions, but research at UVA Health is opening the door to tailored interventions.
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.
UVA Health’s facial reanimation program is one of a handful of programs in the U.S. offering the full spectrum of treatments aimed at giving patients with facial paralysis the ability to create more natural facial expressions.
UVA presented live cases at the premier TVT Conference, including a new technique for patients who can’t be helped by standard treatment.
Researchers at UVA Health developed a new heart function measurement that could significantly reduce deaths and hospitalizations from systolic heart failure and pulmonary hypertension.
UVA Health researchers are using artificial intelligence to advance risk evaluation and treatment options for children with disruptive gastrointestinal disease.
UVA Children’s reduced ED visits and hospital length-of-stay with the first consumer-friendly, EMR-integrated home monitoring platform.
A new vaccine in development by researchers at UVA Health and Virginia Tech could offer broad protection against coronavirus mutations.
UVA Children's and Children's Hospital of Richmond at VCU formed a partnership to offer enhanced pediatric cardiac surgery care.